Li Dean Y
Officer at MRK; Director at RXRX
- Sold, on record
- $5.9M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Feb 10, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice RXRXNoticeJan 9, 2024 2024
Filed to sell 29,000 shares ($396k)
Li Dean Y, Director
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale RXRXRoutineJan 9, 2024 same day
Sold 29,000 shares at $13.66 ($396k)
Li Dean Y, Director
10b5-1 planSold 6.4% of holdings ($6.1M position)421,000 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice MRKNoticeFeb 9, 2024 +31 days
Filed to sell 14,702 shares ($1.8M)
Li Dean Y, Officer
No 10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale MRKNo planFeb 9, 2024 same day
Sold 14,702 shares at $125.50 ($1.8M)
Li Dean Y, Executive VP & President, MRL
No 10b5-1 planSold 24.1% of holdings ($7.6M position)46,242 shares leftFirst sale on recordFollows a Form 144Filing
- 5 Form 144 notice MRKNoticeFeb 4, 2026 +726 days
Filed to sell 15,087 shares ($1.8M)
Li Dean Y, Officer
No 10b5-1 planFiling
- 6 Form 4 sale MRKNo planFeb 4, 2026 same day
Sold 15,087 shares at $118.77 ($1.8M)
Li Dean Y, Executive VP & President, MRL
No 10b5-1 planSold 12.9% of holdings ($13.9M position)102,270 shares leftFiling
- 7 Form 4 sale MRKNo planFeb 10, 2026 +6 days
Sold 10,235 shares at $117.52 ($1.2M)
Li Dean Y, Executive VP & President, MRL
No 10b5-1 planSold 10% of holdings ($12M position)92,035 shares leftFiling
- 8 Form 144 notice MRKNoticeFeb 10, 2026 same day
Filed to sell 10,235 shares ($1.2M)
Li Dean Y, Officer
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Feb 10, 2026 | MRK | Officer | Form 144 notice | 10,235 | $1.2M | Notice | SEC | |
| Feb 10, 2026 | Feb 10, 2026 | MRK | Executive VP & President, MRL | Form 4 sale | 10,235 | $1.2M | 10.0% | No plan | SEC |
| Feb 4, 2026 | Feb 6, 2026 | MRK | Executive VP & President, MRL | Form 4 sale | 15,087 | $1.8M | 12.9% | No plan | SEC |
| Feb 4, 2026 | Feb 4, 2026 | MRK | Officer | Form 144 notice | 15,087 | $1.8M | Notice | SEC | |
| Feb 9, 2024 | Feb 12, 2024 | MRK | Executive VP & President, MRL | Form 4 sale | 14,702 | $1.8M | 24.1% | No plan | SEC |
| Feb 9, 2024 | Feb 9, 2024 | MRK | Officer | Form 144 notice | 14,702 | $1.8M | Notice | SEC | |
| Jan 9, 2024 | Jan 11, 2024 | RXRX | Director | Form 4 sale | 29,000 | $396k | 6.4% | Routine | SEC |
| Jan 9, 2024 | Jan 9, 2024 | RXRX | Director | Form 144 notice | 29,000 | $396k | Notice | SEC | |
| Jan 9, 2024 | Jan 9, 2024 | RXRX | Director | Form 144 notice | 29,000 | $397k | Notice | SEC | |
| Dec 7, 2021 | Dec 9, 2021 | RXRX | Director | Form 4 sale | 15,900 | $326k | 1.2% | Plan not stated | SEC |
| Nov 19, 2021 | Nov 19, 2021 | RXRX | Director | Form 4 sale | 19,100 | $385k | 3.2% | Plan not stated | SEC |